Introducing The Hemealumen Polychromatic Device
The Hemealumen represents the first significant improvement in 100 years on the original Knott UVBI device.
The Hemealumen is designed to deliver a significant amount of wide-spectrum photonic energy over a prolonged period via an energetic photon infusion of the blood.
Device Features
The Hemealumen utilizes multiple light sources and is equipped with:
- A high power dual-wavelength UVA light source
- A high output UVC source
- 60 watts of multiple visible wavelengths
The combined UV sources deactivate the DNA of bacteria, viruses, and other pathogens, thus destroying their ability to multiply and cause disease. Specifically, UV-C light damages the nucleic acid of microorganisms by forming covalent bonds between certain adjacent bases in the DNA.
The principle behind this unique triple UV light emission architecture is based on the Krebs Cycle, promoting energetic ability to increase mitochondrial electron transfer. The Hemealumen provides peak energy absorption spectra unique to both NAD+ and NADH. Nicotinamide adenine dinucleotide (NAD) is involved in redox reactions, carrying electrons from one reaction to another. The coenzyme exists in two forms in cells: NAD+ (an oxidizing agent) and NADH (a reducing agent).
The Treatment
Blood treated with the Hemealumen facilitates the following:
- Renders viruses and bacteria unable to replicate
- Increases capabilities for oxygenation by activating the 2,3-DPG enzyme system, which potentiates oxygen from the heme complex into the tissues
- Enhances mitochondrial energy deficiencies
- Stimulates lymphatic detoxification by restoring functional chylomicron Brownian movement within the blood
- Activates NAD+ and immune cells such as NK Cells, neutrophils, and macrophages, assisting in balancing cytokine production. This activation aids in the destruction of microorganisms, fungi, viruses, and bacteria.
- Dismantles nagalase, a protein produced principally by cancer, viruses, and some bacteria. Nagalase disables the glycoprotein basis for GCMAF production, which binds to macrophages and activates their function, potentially activating other cytotoxic immune cells such as NK cells.
We aim to change the world by creating the most effective viral and bacterial inactivation devices possible, with a focus on global health rather than monetary compensation.
Should an Emerging Infectious Disease (EID) without a current treatment or cure arise, millions of lives could be at risk. We sincerely believe that the Hemealumen has the best chance of addressing such threats to global health!